THERAVANCE BIOPHARMA INC

Ticker: TBPH CUSIP: G8807B106 Class: Common Stock

BALYASNY ASSET MANAGEMENT L.P.'s Holding History (CIK: 0001218710)

Note: Option positions (PUT/CALL) are excluded.

Q3 2025
Shares 20,098 Value ($000) $293 Avg Close $12.64 Range $10.82 - $14.87
Q2 2024
Shares 34,107 Value ($000) $289 Avg Close $9.03 Range $8.13 - $10.44
Q1 2024
Shares 31,285 Value ($000) $281 Avg Close $9.27 Range $8.21 - $11.71
Q3 2023
Shares 13,699 Value ($000) $118 Avg Close $9.65 Range $8.25 - $10.59
Q1 2018
Shares 65,149 Value ($000) $1,580 Avg Close $27.46 Range $22.90 - $30.29
Q4 2017
Shares 88,692 Value ($000) $2,474 Avg Close $29.59 Range $25.20 - $35.90
Q3 2017
Shares 180,600 Value ($000) $6,184 Avg Close $32.70 Range $23.15 - $42.61
Q2 2017
Shares 155,750 Value ($000) $6,205 Avg Close $38.45 Range $34.85 - $43.44
Q1 2017
Shares 217,424 Value ($000) $8,006 Avg Close $31.95 Range $27.80 - $37.18
Q4 2016
Shares 182,365 Value ($000) $5,814 Avg Close $31.02 Range $24.54 - $38.92